AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION: Form 990, tax year 2009

View the entire original 990 at ProPublica ↗

Organization
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION (EIN 23-7033369)
Tax period
2009-06-01 to 2010-05-31
Filed
2011-04-13
IRS object ID
201101039349300705
Schema version
2009v1.4
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2011-04-13T09:07:18-05:00Timestamp
Tax Period End Date2010-05-31TaxPeriodEndDate

Preparer Firm PreparerFirm

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1Tate and TryonBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line12021 L Street NW Suite 400AddressLine1
CityWashingtonCity
StateDCState
ZIP Code20036ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2009-06-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN237033369EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1AMERICAN SOCIETY OF HEALTH-SYSTEMBusinessNameLine1
Business Name Line2PHARMACISTS RESEARCH AND EDUCATION FDTNBusinessNameLine2
FieldValueIRS element (for citing)
Name ControlAMERNameControl
Phone3016648612Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line17272 WISCONSIN AVENUE 2ND FLOORAddressLine1
CityBETHESDACity
StateMDState
ZIP Code20814ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameSTEPHEN J ALLENName
TitleEXECUTIVE VICE PRESIDENT AND CEOTitle
Phone3016648612Phone
Date Signed2011-04-13DateSigned
Authorize Third Party1AuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
NameDEBORAH G KOSNETTName
Phone2022932200Phone
FieldValueIRS element (for citing)
Tax Year2009TaxYear
Build TS2016-02-24 21:20:13ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Name Of Principal Officer PersonSTEPHEN J ALLENNameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line17272 WISCONSIN AVENUE 2ND FLOORAddressLine1
CityBETHESDACity
StateMDState
ZIP Code20814ZIPCode
FieldValueIRS element (for citing)
Gross Receipts3378384GrossReceipts
Group Return For Affiliates0GroupReturnForAffiliates
Organization501cXOrganization501c
Web SiteWWW.ASHPFOUNDATION.ORGWebSite
Type Of Organization CorporationXTypeOfOrganizationCorporation
Year Formation1968YearFormation
State Legal DomicileMDStateLegalDomicile
Activity Or Mission DescriptionFOSTERING SAFE AND EFFECITVE MEDICATION USE. TO PROMOTE THE PUBLIC INTEREST THROUGH DEVELOPMENT OF HIGH QUALITY PHARMACEUTICAL SERVICES IN HEALTH SYSTEMS. TO ENCOURAGE, PROVIDE FOR AND ENGAGE IN SCIENTIFIC RESEARCH, PROFESSIONAL STUDY AND ADVANCEMENT OF THE SCIENCE OF PHARMACY IN HEALTH SYSTEMS. TO IMPROVE THE QUALITY AND INCREASE THE AVAILABILITY OF PHARMACEUTICAL SERVICES TO THE PUBLIC.ActivityOrMissionDescription
Nbr Voting Members Governing Body11NbrVotingMembersGoverningBody
Nbr Independent Voting Members9NbrIndependentVotingMembers
Total Nbr Employees0TotalNbrEmployees
Total Nbr Volunteers100TotalNbrVolunteers
Total Gross UBI0TotalGrossUBI
Net Unrelated Business Txbl Income0NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year1610656ContributionsGrantsPriorYear
Contributions Grants Current Year1993575ContributionsGrantsCurrentYear
Program Service Revenue Prior Year131189ProgramServiceRevenuePriorYear
Program Service Revenue CY155612ProgramServiceRevenueCY
Investment Income Prior Year-2139511InvestmentIncomePriorYear
Investment Income Current Year1220437InvestmentIncomeCurrentYear
Other Revenue Prior Year-8864OtherRevenuePriorYear
Other Revenue Current Year-9853OtherRevenueCurrentYear
Total Revenue Prior Year-406530TotalRevenuePriorYear
Total Revenue Current Year3359771TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year564069GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY497824GrantsAndSimilarAmntsCY
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year1068454SalariesEtcPriorYear
Salaries Etc Current Year1057637SalariesEtcCurrentYear
Total Prof Fundrsng Exp CY0TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year352987TotalFundrsngExpCurrentYear
Other Expense Prior Year791819OtherExpensePriorYear
Other Expenses Current Year748340OtherExpensesCurrentYear
Total Expenses Prior Year2424342TotalExpensesPriorYear
Total Expenses Current Year2303801TotalExpensesCurrentYear
Revenues Less Expenses Prior Year-2830872RevenuesLessExpensesPriorYear
Revenues Less Expenses CY1055970RevenuesLessExpensesCY
Total Assets BOY8730826TotalAssetsBOY
Total Assets EOY9832251TotalAssetsEOY
Total Liabilities BOY226249TotalLiabilitiesBOY
Total Liabilities EOY271704TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY8504577NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY9560547NetAssetsOrFundBalancesEOY
Mission DescriptionThe mission of the ASHP Foundation is to improve the health and well-being of patients in hospitals and health systems through appropriate, safe and effective medication use. The Foundation provides leadership and conducts education and research activities that foster the coordination of interdisciplinary medication management leading to optimal patient outcomes. Emphasis is given to programs that will have a major impact on advancing pharmacy practice in hospitals and health systems, thereby improving public health.MissionDescription
Significant New Program Services0SignificantNewProgramServices
Significant Change0SignificantChange
Expense768245Expense
Grants132560Grants
Revenue155612Revenue
DescriptionEXPANSION OF PHARMACISTS' DIRECT PATIENT CARE AND LEADERSHIP ROLES ASHP Foundation Research Advisory Panel-The Research Advisory Panel (RAP) met once during FY 10 and the Senior Director for Research and Operations worked closely with several panel members to facilitate implementation of several RAP recommendations for the Foundation's research agenda. These included guidance on the Foundation's grant review process, research misconduct language, and the future role of the RAP.Center for Health-System Pharmacy Leadership-The Center was developed as a collaborative programmatic offering of ASHP and the ASHP Foundation, and is administered by the Foundation. The Center has been in operation since January 2007 and its primary objectives are to: (1) assure that pharmacy leaders have the knowledge necessary to proactively influence the advancement of the medication-use process by providing competency-based education opportunities, (2) provide leadership development programs for students, residents and new practitioners that promote the important role of the pharmacist as a change agent and a leader in patient care, (3) integrate into health-system leadership decision-making the critical role for pharmacists as active participants in achieving organizational objectives, (4) conduct research on effective pharmacy management and leadership in achieving the objectives of hospitals and health systems, as well as improving community disease prevention and health promotion efforts and (5) explore the purpose and value of a credential for hospital and health-system pharmacy leaders that recognizes competencies to direct the medication-use systems enterprise and promote safety and cost-effective medication outcomes.The Center Advisory Panel (CAP)-This advisory panel was established in FY 08 and is a 12-member group that serves as an external resource of experts providing an environmental scan of practice issues and significant events that might affect the Center's plan of action. In addition, members provide expert advice on the Center's current direction, program development and possible actions that the Center should consider as it builds its program portfolio. The CAP met twice in FY 10.Pharmacy Leadership Academy-The Pharmacy Leadership Academy is supported by Amgen. The Pharmacy Leadership Academy is designed to provide additional comprehensive training to pharmacy leaders beyond what is learned in pharmacy residencies, short courses and other educational programs. The Academy provides leadership training applicable to clinical and administrative pharmacy practitioners in small to large hospitals and health systems who aspire to leadership positions in health-system pharmacy.Leadership Learning Community-The Center for Health-System Pharmacy Leadership hosted a successful learning community at the June 2010 ASHP Summer Meeting entitled "Leading Results with NQF 18." The 5-session series offered over 11 hours of material and had an esteemed faculty of senior pharmacists and health-system executives from a variety of health-system settings.Pharmacy Leadership Institute (PLI)-Since 2008, the Section for Pharmacy Practice Managers has collaborated with Boston University to establish the PLI as a major program within the Center's portfolio and to have it serve as its capstone program. The Pharmacy Leadership Institute uses relevant program curriculum, high-quality instruction, and peer interaction to broaden business skills, managerial versatility, and the extraordinary leadership demanded of today's health-system pharmacy leaders. The experience enables pharmacist leaders to develop a new way of thinking and a new set of behaviors to meet the demanding challenges facing pharmacy. PLI graduates have become a source of leadership experts serving the Center's initiatives.Conversations with Health-System Pharmacy's Most Influential Leader's Video-ASHP past president and Whitney Award Recipient, Sara White, provided the Foundation with ongoing support and volunteered her time to help produce a series of videos with some of the most influential health-system pharmacy practice leaders. The videos are hosted on the ASHP Foundation Web site as a leadership resource and a source of motivation for health-system pharmacy professionals. Two new videos were added in the fall of 2009, expanding the total of videos to nine.Leadership Speakers Bureau-The Leadership Speakers Bureau (LSB) is the first program of the Center for Health-System Pharmacy Leadership developed specifically for students. The LSB is a collaboration of the Center and ASHP's Section of Pharmacy Practice Managers, Student and New Practitioners Forum, and the State Affiliates Division, along with external consultants. Pharmacists who are ASHP state affiliate members are the primary speakers. They draw upon their personal and professional experiences to encourage students to embrace leadership as part of their professional obligation. Supported by a grant from Roche, 14 schools of pharmacy participated in the program during FY 10.Community Health Systems Leadership Seminar Series-In February, 2010, the Center for Health-System Pharmacy Leadership launched an eight-month leadership seminar series for the pharmacists employed by Community Health Systems (CHS), the nation's third largest health system. This program has been customized to meet the key leadership needs and challenges for the CHS pharmacy leadership team across the nation. Topics include leadership subjects that have been presented in past leadership learning communities sponsored by the Center at the ASHP Summer Meeting, and are presented via live, web-based distance learning mechanisms.Leadership Resource Center- Sponsored by Baxter Healthcare, Inc., this program was developed in 2009 and launched in February of 2010 as a web-based resource that is part of the ASHP Foundation's website. The primary goal of the Leadership Resource Center is to have an ongoing and continuously updated source of leadership information and tools to assist pharmacists at all stages of their careers.Student Leadership Development Workshop-The Center for Health-System Pharmacy leadership worked with the Section of Pharmacy Practice Managers to support a series of three-hour leadership development workshops for pharmacy students at three ASHP state affiliate meetings. Discussions are underway to determine how to make this workshop an ongoing program supported by the ASHP Foundation.Pharmacy Student Clinical Skills Competition-This is the third year that the Foundation has sponsored the Pharmacy Student Clinical Skills Competition (CSC) at the ASHP Midyear Clinical Meeting. Each year the number of participating schools continues to grow and in December 2009 102 teams who won preliminary competitions at their local pharmacy schools participated in the competition. During the CSC, students demonstrate their skills by assessing patient information and current therapy, identifying and prioritizing drug therapy problems, identifying treatment goals, and recommending a pharmacist care plan. The 2009 recipients were Tamara Spraker and Sijy Mathew of the University of Texas at Austin.Demonstrating Pharmacists' Value: A Systematic Evidence Review-Dr. Marie Chisholm-Bums of the University of Arizona completed a systematic evidence review entitled "Demonstrating Pharmacists' Impact on Therapeutic, Safety, Humanistic and Economic Health Outcomes: A Systematic Review and Meta-analyses." She presented her review at the 2009 ASHP Midyear Clinical Meeting.Harvey A. K. Whitney Award Lecture Collection Program-The Harvey A.K. Whitney Award is the most prestigious award in health-system pharmacy. The Whitney Lecture Collection Program includes a web-based program for dissemination of Whitney lectures, a dessert reception following the Whitney Award dinner at the ASHP Summer Meeting, and a reception at the ASHP Midyear Clinical Meeting that enables residents to meet many of the recipients of the Whitney award. Recipients present a lecture at the award ceremony, which is later published. Since 1990, the ASHP Foundation has offered a compilation of these lectures from 1950 through present day to residents, residency directors and directors of pharmacy participating in ASHP-accredited residency programs. The current web-based site provides access to 60 lectures that can be browsed by title, author, publication date or keyword. Updates for the 2010 year include the addition of Charles D. Hepler's lecture and the addition of brief video clips containing 6 to 8 of the past recipients.Other programs-Literature Awards ProgramPharmacy Practice Model InitiativeResearch Boot CampSterile Products Outsourcing ToolWalter Jones Memorial Pharmacy Student Financial AidASHP Student Leadership AwardWilliam A. Zellmer Leadership Lecture ProgramDescription

Activity2 Activity2

FieldValueIRS element (for citing)
Expense548257Expense
Grants212275Grants
DescriptionADVANCEMENT OF OPTIMAL PATIENT MEDICATION OUTCOMES:ASHP Foundation Junior Investigator Research Grant-Twenty-five applications were received for the ASHP Foundation Junior Investigator Research Grant during the FY 10 cycle. This grant is offered to new pharmacist investigators and is intended to support practice-based medication-use research. Grant funds are provided by the ASHP Foundation through Joseph A. Oddis Endowment. A seven-member review panel composed of pharmacist and physician researchers recommended award of the following grants: "Nonadherence with INR Monitoring and Anticoagulant Complications" which will be conducted by Daniel M. Witt, Pharm.D., of Kaiser Permanente Colorado and Mark A. Crowther, M.D. of McMaster University and "Improving Pharmacist-led Electronic Medication Reconciliation" which will be conducted by Shobha Phansalkar, R.Ph., Ph.D and David Bates, M.D. of The Brigham and Woman's Hospital. Studies funded during the FY 08 and FY 09 grant cycles progressed during FY 10.American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowship-The ASHP Foundation withheld its annual funding of the AFPE Pre-Doctoral Fellowship in the spring of 2009 but was able to partner with ASHP in May of 2010 to jointly fund this fellowship in the coming year. We are awaiting the selection of the student in 2010 who will benefit from the ASHP/ASHP Foundation support.Antithrombotic Pharmacotherapy Traineeship Program-In collaboration with ASHP as part of a multi-tiered educational program, the Foundation received funding for the 2009/2010 Antithrombotic Pharmacotherapy Traineeship from sanofi-aventis. The 2009/2010 program offering was revised to include a comprehensive web-based distance education program and comparison of anti thrombotic medication related pre/post process and patient outcomes. The traineeship concluded with a 5-day structured experiential program that prepared pharmacists to establish and maintain specialized services for the management of patients' antithrombotic therapy.Critical Care Traineeship Program-This program was last conducted in May 2009 and was a program that was unfunded in FY 10. Staff continues to seek programmatic support for what is one of the most popular traineeship programs. Fed. Services Jr. Invest. Grant Program: Optimizing Chronic Drug Therapy in the Elderly- For FY 07 through FY 09, program support was provided by Abbott and the research focus was medication adherence in patients with either auto-immune diseases, dyslipidemia, HIV/AIDS, psychiatric disorders, or stages 3 and 4 renal disease. Research supported by the FY 07, FY 08 and FY 09 programs is ongoing.Hospital Pharmacist - Hospitalist Collaborations-Sanofi-aventis provided sponsorship for this program that studies multidisciplinary initiatives between hospitalists and hospital pharmacists focused on venous thromboembolism prevention/treatment or glycemic control in hospitalized patients. Research from these two programs from FY 07 and FY 08 is ongoing. FY 07 recipient Dr. Rachel Hroncich presented findings at the 2009 ASHP Midyear Clinical Meeting.Emergency Physician/Hospital Pharmacist Research Grant Program-Ortho-McNeil provided sponsorship for this program which supports research, conducted by hospital pharmacists and emergency physicians, related to the care of patients with infectious diseases who present to the emergency department. A ten-member review panel composed of pharmacists and emergency physicians recommended award of the following grants: "ED Pharmacists Optimize Antimicrobial Use Process in Severe Sepsis and Septic Shock," which will be conducted by Maria l. Rudis, Pharm.D. and Christopher S. Russi, D.O. of Mayo Clinic Rochester and "The Value of MRSA Nares Carriage Status for Treatment of Skin and Soft Infections in the Emergency Department," which will be conducted by Nicole M. Acquisto, Pharm.D. and Sharon G. Humiston, M.D., M.P.H. of the University of Rochester Medical Center.Oncology Patient Care Traineeship Program-Support for the 2009/2010 program was provided by Amgen. Eight trainees were selected from 24 applicants. Participants received their experiential training at the following four sites: Duke University Medical Center, The Johns Hopkins Hospital, University of Texas M.D. Anderson Cancer Center, and the University of Washington Medical Center. Pain and Palliative Care Traineeship Program-Endo Pharmaceuticals provided support for redesign of the former Pain Management Traineeship to expand its focus to include palliative care and to transform the distance education component to reach more pharmacists. The distance education program will include a Pain Management and Palliative Care Self-Assessment Tool and modules to address application of the principles of pain management and palliative care.Pharmacy Residency Excellence Awards Program-The 2009 Pharmacy Residency Excellence Awards Program was supported by Amgen, Inc. This unique national competition recognizes excellence and leadership in the training and mentoring of pharmacy residents. The objectives of this program are to: (1) recognize the achievements of residency programs and pharmacists who have demonstrated excellence and leadership in the training of pharmacy residents, and (2) to widely disseminate the results of these accomplishments to foster innovations in pharmacy resident training.Pharmacy Resident Practice-Based Research Grant Program-Sixty-five applications were received for the 2009 Pharmacy Resident Practice-Based Research Grant Program. This program was funded through the ASHP dues contribution to the Foundation. This grant is offered to pharmacy residents participating in an ASHP-accredited residency program and is intended to support health services research related to medication use.Promoting Influenza Prevention: Pharmacists as Immunization Advocates-CSL Biotherapies provided support for Promoting Influenza Prevention: Pharmacists as Immunization Advocates. This program supports demonstration projects that focus on the pharmacist's role in promoting vaccination against seasonal influenza. Two $25,000 grants are being offered through this program. Twelve applications were received for the April 16, 2010 deadline. Grantees selection is occurring during FY 11 and the research will begin during the 2010/2011 flu season.University of Alabama Musculoskeletal CERTs-Foundation staff members, Drs. Daniel Cobaugh and Cynthia LaCivita continued to collaborate with the Agency for Health Care Research and Quality (AHRQ)-funded Musculoskeletal Center for Education and Research in Therapeutics (CERTs) at the University of Alabama. In FY 10, this collaboration resulted in two publications: (1) Miller MJ, Allison JJ, Schmitt MR, Ray MN, Funkhouser EM, Cobaugh DJ, Saag KG, LaCivita C. using single-item health literacy screening questions to identify patients who read written nonsteroidal antiinflammatory medicine information provided at pharmacies; (2) Miller MJ, Schmitt MR, Allison JJ, Cobaugh DJ, Ray MN, Saag KG. The role of health literacy and written medicine information in nonsteroidal antiinflammatory drug risk awareness. Multi-Site Unsolicited Grant-In April 2008, the ASHP Foundation made a grant award to Jeffrey Rothschild, M.D. and William Churchill, R.Ph., of the Brigham and Women's Hospital, for a study entitled "Medication Errors Recovered by Emergency Department Pharmacists." This multicenter study also included the University of Wisconsin Hospitals and Clinics and Cedars Sinai Medical Center. The results of this study were presented at the 2009 Scientific Congress of the American College of Emergency Physicians and at the 2009 ASHP Midyear Clinical Meeting. Dr. Rothchild's research was also published in the Annals of Emergency Medicine.Description

Activity3 Activity3

FieldValueIRS element (for citing)
Expense472448Expense
Grants152991Grants
DescriptionDESIGN AND STUDY OF SAFE AND EFFECTIVE MEDICATION-USE SYSTEMS:2009 Award for Excellence in Medication-Use Safety-Supported by a grant from the Cardinal Health Foundation, this program is designed to recognize a pharmacist-led multidisciplinary team that makes significant institution-wide system improvements relating to medication use. The program is in its sixth year and is the only national-level program that recognizes the pharmacist's leadership role in the medication-use process. The three 2009 finalist organizations were chosen from 34 applicants using structured selection criteria established by an independent multidisciplinary panel of experts in the field of medication safety and healthsystem administration. The Women & Children's Hospital of Buffalo Kaleida Health System, NY received the $50,000 award. The two finalists, Henry Ford Hospital in Detroit, MI and Rex Healthcare in Raleigh, NC each received $10,000. The 2009 Award for Excellence video highlighted the success stories of the recipient and finalists and was presented to more than 8,000 pharmacists at the 2009 ASHP Midyear Clinical Meeting opening general session in December in Las Vegas, NY. A dinner was also held at the Midyear to recognize the finalist and recipient teams.Medication Safety Team Grant: Optimizing Bedside Technology Solutions-The three-year commitment from Omnicell to support this program ended in May of 2009. Research by the six recipients of this grant over a 3-year period is ongoing. Presentations by four of the grant recipients are planned for the 2010 ASHP Midyear Clinical meeting. These researchers have also begun to prepare manuscripts for submission to biomedical journals.Medication Continuity of Care Record Research-This program evaluation, sponsored with support from sanofi-aventis, is ongoing at the University of Pittsburgh School of Pharmacy. This evaluation, entitled "Development of a Continuity of Care Record: Bridging the Medication-Use Gap from Hospital to Home," is being conducted by Kim C. Coley, Pharm.D. She is studying the use of a continuity of care record and medication therapy management in the transition of patients from hospital to home.Pandemic Influenza Assessment Tool-Roche provided a grant to develop a Pandemic Readiness and Emergency Preparedness Resource Center which is available at www.pharmacyready.org. This site contains the Pandemic Influenza Assessment Tool for Health-System Pharmacy Departments(TM) along with practice resources, RSS feeds and benchmarking data. The availability of this tool was communicated to ASHP members and other health professionals through more than 40 dissemination vehicles, including the ASHP Foundation and ASHP web sites, electronic newsletters, ASHP meeting communications, and social networking sites. Between June 2009 and May 2010, during an H1N1 influenza pandemic, there were over 150,000 visits to this web-based tool.University of Iowa Medication Safety Grant-Following publication of their primary article related to this 2005 ASHP Foundation grant, Frank H. Morris, Jr., M.D and Paul W. Abramowitz, Pharm.D., of the University of Iowa Medical Center, published additional findings related to nursing perceptions about barcode-supported medication administration. (See: Morriss FH Jr, Abramowitz PW, Carmen L, Wallis AB. "Nurses Don't Hate Change" -- survey of nurses in a neonatal intensive care unit regarding the implementation, use and effectiveness of a bar code medication administration system.Description
FieldValueIRS element (for citing)
Total Program Service Expense1788950TotalProgramServiceExpense
Described In501 C31DescribedIn501C3
Schedule B Required1ScheduleBRequired
Political Activities0PoliticalActivities
Lobbying Activities0LobbyingActivities
Donor Advised Funds0DonorAdvisedFunds
Conservation Easements0ConservationEasements
Collections Of Art0CollectionsOfArt
Credit Counseling0CreditCounseling
Term Or Permanent Endowments1TermOrPermanentEndowments
Balance Sheet Amounts Reported1BalanceSheetAmountsReported
Independent Audit Financial Stmt1IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt0ConsolidatedAuditFinancialStmt
School0School
Foreign Office0ForeignOffice
Foreign Activities0ForeignActivities
More Than5000 K To Organizations0MoreThan5000KToOrganizations
More Than5000 K To Individuals0MoreThan5000KToIndividuals
Professional Fundraising0ProfessionalFundraising
Fundraising Activities1FundraisingActivities
Gaming0Gaming
Hospital0Hospital
Grants To Organizations1GrantsToOrganizations
Grants To Individuals1GrantsToIndividuals
Schedule J Required1ScheduleJRequired
Tax Exempt Bonds0TaxExemptBonds
Excess Benefit Transaction0ExcessBenefitTransaction
Prior Excess Benefit Transaction0PriorExcessBenefitTransaction
Loan To Officer Or DQP0LoanToOfficerOrDQP
Grant To Related Person0GrantToRelatedPerson
Bsnss Rltnshp With Organization0BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member0BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp0OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions0DeductibleNonCashContributions
Deductible Contributions Of Art0DeductibleContributionsOfArt
Terminated0Terminated
Partial Liquidation0PartialLiquidation
Disregarded Entity0DisregardedEntity
Related Entity1RelatedEntity
Related Org Controlled Entity0RelatedOrgControlledEntity
Transfers To Exempt Non Chrtbl Org1TransfersToExemptNonChrtblOrg
Activities Conducted Partnership0ActivitiesConductedPartnership
Schedule O Required1ScheduleORequired
Number Forms Transmitted With109642NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Compliance With Backup Witholding1ComplianceWithBackupWitholding
Number Of Employees0NumberOfEmployees
Unrelated Business Income0UnrelatedBusinessIncome
Foreign Financial Account0ForeignFinancialAccount
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTrans
Taxable Party Notification0TaxablePartyNotification
Non Deductible Contributions0NonDeductibleContributions
Quid Pro Quo Contributions1QuidProQuoContributions
Quid Pro Quo Disclosure1QuidProQuoDisclosure
Form8282 Property Disposed Of0Form8282PropertyDisposedOf
Funds To Pay Premiums0FundsToPayPremiums
Premiums Paid0PremiumsPaid
Form8899 Filed0Form8899Filed
Form1098 C Filed0Form1098CFiled
Nbr Voting Governing Body Members11NbrVotingGoverningBodyMembers
Number Independent Voting Members9NumberIndependentVotingMembers
Family Or Business Relationship1FamilyOrBusinessRelationship
Delegation Of Management Duties0DelegationOfManagementDuties
Changes To Organizing Docs0ChangesToOrganizingDocs
Material Diversion Or Misuse0MaterialDiversionOrMisuse
Members Or Stockholders0MembersOrStockholders
Election Of Board Members1ElectionOfBoardMembers
Decisions Subject To Approval0DecisionsSubjectToApproval
Minutes Of Governing Body1MinutesOfGoverningBody
Minutes Of Committees0MinutesOfCommittees
Officer Mailing Address0OfficerMailingAddress
Local Chapters0LocalChapters
Form990 Provided To Governing Body1Form990ProvidedToGoverningBody
Conflict Of Interest Policy1ConflictOfInterestPolicy
Annual Disclosure Covered Persons1AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement1RegularMonitoringEnforcement
Whistleblower Policy1WhistleblowerPolicy
Document Retention Policy1DocumentRetentionPolicy
Compensation Process CEO1CompensationProcessCEO
Compensation Process Other0CompensationProcessOther
Investment In Joint Venture0InvestmentInJointVenture
States Where Copy Of Return Is FiledMDStatesWhereCopyOfReturnIsFiled
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1ELIZABETH HARTNETTBusinessNameLine1
FieldValueIRS element (for citing)
Telephone Number3016648612TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line17272 WISCONSIN AVENUE 2ND FLOORAddressLine1
CityBETHESDACity
StateMDState
ZIP Code20814ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (15 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekIndividual Trustee Or DirectorIndividualTrusteeOrDirectorOfficerOfficerReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensationHighest Compensated EmployeeHighestCompensatedEmployee
DAVID R GAUGH
CHAIR1.00XX000
JANET A SILVESTER MBA
VICE CHAIR1.00XX000
HENRI R MANASSE JR P
PRESIDENT/ASHP PRESIDENT1.00XX064419974836
PAUL W ABRAMOWITZ PHAR
TREASURER1.00XX000
STEPHEN J ALLEN MS FA
SECRETARY/EVP40.00XX217376029535
BARBARA BALIK RN MS E
DIRECTOR AT LARGE1.00X000
KEVIN J COLGAN MA FA
DIRECTOR AT LARGE1.00X050000
MICHAEL S FLAGSTAD MS
DIRECTOR AT LARGE1.00X000
DALLAS J HOWE
DIRECTOR AT LARGE1.00X000
BRUCE E SCOTT PHARMD
DIRECTOR AT LARGE1.00X000
GORDON S WILLCOX
DIRECTOR AT LARGE1.00X000
RICHARD WALLING
Director Ctr for Health-40.00135636014825X
DANIEL COBAUGH
Sr Dir for Research and40.00127533020132X
Myrna Konajeski
DIR OF DEVELOPMENT40.0010386302056X
cynthia lacivita
dir education and specia40.00104487012259X
FieldValueIRS element (for citing)
Total Reportable Comp From Org688895TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs649199TotalReportableCompFrmRltdOrgs
Total Other Compensation153643TotalOtherCompensation
Number Individuals GT100 K5NumberIndividualsGT100K
Formers Listed0FormersListed
Total Comp GT150 K1TotalCompGT150K
Compensation From Other Sources0CompensationFromOtherSources
Number Of Contractors GT100 K0NumberOfContractorsGT100K
Fundraising Events32747FundraisingEvents
All Other Contributions1960828AllOtherContributions
Total Contributions1993575TotalContributions

Program Service Revenue ProgramServiceRevenue

FieldValueIRS element (for citing)
DescriptionPHARMACY LEADERSHIP ACDescription
Business Code900099BusinessCode
Total Revenue Column155612TotalRevenueColumn
Related Or Exempt Function Income155612RelatedOrExemptFunctionIncome
FieldValueIRS element (for citing)
Total Program Service Revenue155612TotalProgramServiceRevenue

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column234758TotalRevenueColumn
Exclusion$234,758ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

FieldValueIRS element (for citing)
Securities985679Securities

Gain Or Loss GainOrLoss

FieldValueIRS element (for citing)
Securities985679Securities

Net Gain Or Loss Investments NetGainOrLossInvestments

FieldValueIRS element (for citing)
Total Revenue Column985679TotalRevenueColumn
Exclusion$985,679ExclusionAmount
FieldValueIRS element (for citing)
Gross Income Fundraising Events8760GrossIncomeFundraisingEvents
Cntrbtns Rprtd Fundraising Events32747CntrbtnsRprtdFundraisingEvents
Fundraising Direct Expenses18613FundraisingDirectExpenses

Net Income From Fundraising Events NetIncomeFromFundraisingEvents

FieldValueIRS element (for citing)
Total Revenue Column-9853TotalRevenueColumn
Exclusion-$9,853ExclusionAmount

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column3359771TotalRevenueColumn
Related Or Exempt Function Income155612RelatedOrExemptFunctionIncome
Unrelated Business Revenue0UnrelatedBusinessRevenue
Exclusion$1,210,584ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

FieldValueIRS element (for citing)
Total421110Total
Program Services421110ProgramServices

Grants To Domestic Individuals GrantsToDomesticIndividuals

FieldValueIRS element (for citing)
Total76714Total
Program Services76714ProgramServices

Comp Current Officers Directors CompCurrentOfficersDirectors

FieldValueIRS element (for citing)
Total251190Total
Program Services166486ProgramServices
Management And General12880ManagementAndGeneral
Fundraising71824Fundraising

Other Salaries And Wages OtherSalariesAndWages

FieldValueIRS element (for citing)
Total671102Total
Program Services445880ProgramServices
Management And General29850ManagementAndGeneral
Fundraising195372Fundraising

Pension Plan Contributions PensionPlanContributions

FieldValueIRS element (for citing)
Total44810Total
Program Services30448ProgramServices
Management And General3752ManagementAndGeneral
Fundraising10610Fundraising

Other Employee Benefits OtherEmployeeBenefits

FieldValueIRS element (for citing)
Total41309Total
Program Services24103ProgramServices
Management And General5105ManagementAndGeneral
Fundraising12101Fundraising

Payroll Taxes PayrollTaxes

FieldValueIRS element (for citing)
Total49226Total
Program Services38248ProgramServices
Management And General3666ManagementAndGeneral
Fundraising7312Fundraising

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total9600Total
Management And General9600ManagementAndGeneral

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total24330Total
Program Services18995ProgramServices
Management And General1185ManagementAndGeneral
Fundraising4150Fundraising

Occupancy Occupancy

FieldValueIRS element (for citing)
Total56790Total
Program Services31206ProgramServices
Management And General11948ManagementAndGeneral
Fundraising13636Fundraising

Travel Travel

FieldValueIRS element (for citing)
Total127006Total
Program Services100596ProgramServices
Management And General22743ManagementAndGeneral
Fundraising3667Fundraising

Depreciation Depletion DepreciationDepletion

FieldValueIRS element (for citing)
Total46400Total
Program Services29356ProgramServices
Management And General17044ManagementAndGeneral

Other Expenses OtherExpenses (5 entries)

DescriptionDescriptionTotalTotalProgram ServicesProgramServicesManagement And GeneralManagementAndGeneralFundraisingFundraising
CONTRACT SERVICES3929993432333414615620
GENERAL EXPENSES9454576578249915468
temporary services9220461013833227
bank charges and misc60636063
SPECIAL EVENT EXPENSE T-18613-18613

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total2303801Total
Program Services1788950ProgramServices
Management And General161864ManagementAndGeneral
Fundraising352987Fundraising

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY703376BOY
EOY1019149EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

FieldValueIRS element (for citing)
BOY156062BOY
EOY214572EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

FieldValueIRS element (for citing)
BOY2918BOY
EOY9325EOY
FieldValueIRS element (for citing)
Land Buildings Equipment Basis195413LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec130081LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

FieldValueIRS element (for citing)
BOY82685BOY
EOY65332EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

FieldValueIRS element (for citing)
BOY7687225BOY
EOY8377415EOY

Other Assets Total OtherAssetsTotal

FieldValueIRS element (for citing)
BOY98560BOY
EOY146458EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY8730826BOY
EOY9832251EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY114368BOY
EOY194520EOY

Deferred Revenue DeferredRevenue

FieldValueIRS element (for citing)
BOY59406BOY
EOY77184EOY

Other Liabilities OtherLiabilities

FieldValueIRS element (for citing)
BOY52475BOY
EOY0EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY226249BOY
EOY271704EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

FieldValueIRS element (for citing)
BOY1467454BOY
EOY1869549EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY2266374BOY
EOY2912954EOY

Permanently Restricted Net Assets PermanentlyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY4770749BOY
EOY4778044EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY8504577BOY
EOY9560547EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY8730826BOY
EOY9832251EOY
FieldValueIRS element (for citing)
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or Review0AccountantCompileOrReview
FS Audited1FSAudited
Audit Committee0AuditCommittee
Financial Statement SeparateXFinancialStatementSeparate
Federal Grant Audit Required0FederalGrantAuditRequired

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Supporting Organization509a3XSupportingOrganization509a3
Supporting Org509a3 Type1XSupportingOrg509a3Type1
Contrib By Controlling Individual0ContribByControllingIndividual
Contribution By Related Party0ContributionByRelatedParty
Contrib By35 Controlled Entity0ContribBy35ControlledEntity

Supported Org Information SupportedOrgInformation

Name Name

FieldValueIRS element (for citing)
Business Name Line1AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTSBusinessNameLine1
FieldValueIRS element (for citing)
EIN520807628EIN
Type Of Organization501(c)(6)TypeOfOrganization
Listed In Governing Doc0ListedInGoverningDoc
Supported Organization Notified1SupportedOrganizationNotified
Organized In US1OrganizedInUS
Amount$26,682Amount
FieldValueIRS element (for citing)
Total Number Of Supported Orgs1TotalNumberOfSupportedOrgs
Sum Of Amounts26682SumOfAmounts

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

FieldValueIRS element (for citing)
Contributor NumberRESTRICTEDContributorNumber

Contributor Name Business ContributorNameBusiness

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor Address US ContributorAddressUS

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Aggregate ContributionsRESTRICTEDAggregateContributions

Schedule D IRS990ScheduleD

Current Year CurrentYear

FieldValueIRS element (for citing)
Beginning Of Year Balance5554292BeginningOfYearBalance
Contributions7295Contributions
Investment Earnings Or Losses899095InvestmentEarningsOrLosses
Other Expenditures526354OtherExpenditures
End Of Year Balance5934328EndOfYearBalance

Current Year Minus1 Year CurrentYearMinus1Year

FieldValueIRS element (for citing)
Beginning Of Year Balance6505305BeginningOfYearBalance
Contributions900Contributions
Investment Earnings Or Losses-1659001InvestmentEarningsOrLosses
Other Expenditures-707088OtherExpenditures
End Of Year Balance5554292EndOfYearBalance
FieldValueIRS element (for citing)
Board Designated EOY Balance0.19480BoardDesignatedEOYBalance
Permanent Endowment EOY Balance0.80520PermanentEndowmentEOYBalance
Term Endowment EOY Balance0.00000TermEndowmentEOYBalance
Endowments Held By Unrelated Orgs0EndowmentsHeldByUnrelatedOrgs
Endowments Held By Related Orgs0EndowmentsHeldByRelatedOrgs

Other Land Buildings OtherLandBuildings

FieldValueIRS element (for citing)
Other Cost Or Other Basis195413OtherCostOrOtherBasis
Depreciation130081Depreciation
Book Value65332BookValue
FieldValueIRS element (for citing)
Total Of Book Value Land Buildings65332TotalOfBookValueLandBuildings
Total Revenue3359771TotalRevenue
Total Expenses2303801TotalExpenses
Excess Or Deficit For Year1055970ExcessOrDeficitForYear
Total Adjustments0TotalAdjustments
Excess Or Deficit Per FS1055970ExcessOrDeficitPerFS
Tot Revenue Etc Audited Fincl Stmt3424805TotRevenueEtcAuditedFinclStmt
Donated Srvc And Use Of Facilities46421DonatedSrvcAndUseOfFacilities
Other Revenues18613OtherRevenues
Revenue Not Rptd F99065034RevenueNotRptdF990
Revenue Subtotal3359771RevenueSubtotal
Revenue Not Rptd On Fin Stmt0RevenueNotRptdOnFinStmt
Total Revenue Per Form9903359771TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt2368835TotExpensesEtcAuditedFinclStmt
Donated Services Use Of Facilities46421DonatedServicesUseOfFacilities
Other Expenses Included18613OtherExpensesIncluded
Expenses Not Rptd F99065034ExpensesNotRptdF990
Expenses Subtotal2303801ExpensesSubtotal
Expenses Not Rptd On Fin Stmt0ExpensesNotRptdOnFinStmt
Total Expenses Per Form9902303801TotalExpensesPerForm990

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (4 entries)

IdentifierIdentifierReturn ReferenceReturnReferenceExplanationExplanation
Part V, Line 4:Description of Intended Use of Endowment Funds:THE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH WAS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS.
Part X:Description of Uncertain Tax Positions Under FIN 48:Management did not identify any uncertain income tax positions warranting a liability accrual on the financial statements. The Foundation believes it is no longer subject to U.S. Federal, state, and local income tax examinations by taxing authorities for years beginning before 2006.
Part XII, Line 2d - Other Adjustments:special event direct expenses: 18613.
Part XIII, Line 2d - Other Adjustments:special event direct expenses: 18613.

Schedule G IRS990ScheduleG

Events Information EventsInformation

FieldValueIRS element (for citing)
Name Of Event1WALTER JONES GOLF CLASSICNameOfEvent1
Gross Receipts Event141507GrossReceiptsEvent1
Charitable Contributions Event132747CharitableContributionsEvent1
Gross Revenue Event18760GrossRevenueEvent1
Rent Facility Costs Event111101RentFacilityCostsEvent1
Other Direct Expenses Event17512OtherDirectExpensesEvent1
Gross Receipts Total41507GrossReceiptsTotal
Charitable Contributions Total32747CharitableContributionsTotal
Gross Revenue Total Events8760GrossRevenueTotalEvents
Rent Facility Costs Total Events11101RentFacilityCostsTotalEvents
Other Direct Expenses Total Events7512OtherDirectExpensesTotalEvents
Direct Expense Summary Events18613DirectExpenseSummaryEvents
Net Income Summary-9853NetIncomeSummary

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Records Maintained1RecordsMaintained

Recipient Table RecipientTable (28 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEIN Of RecipientEINOfRecipientIRC SectionIRCSectionAmount Of Cash GrantAmountOfCashGrantPurpose Of GrantPurposeOfGrant
ALLINA HOSPITALS AND CLINICS
PO Box 43MinneapolisMN55440363261413501(C)(3)129102009 medication safety grant
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
7272 Wisconsin AveBETHESDAMD20814520807628501(C)(6)26682clinical skills competition grant
ARIZONA BOARD OF REGENTS
PO BOX 3308TUCSONAZ857223308860779656501(C)(3)39277jr investigator grant; pharmacist value grants
BIOMEDICAL RESEARCH INSTITUTE OF NEW MEXICO
1501 SAN PEDRO DRIVE SEALBUQUERQUENM87108850374063501(C)(3)6753JR INVESTIGATOR GRANT
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115042312909501(C)(3)39852research grant-medical errors by emergency dept physicians
CINCINNATI FOUNDATION FOR BIOMEDICAL RESEARCH AND EDUCATION
3200 VINE STREETCINCINNATIOH452203113479691158500FEDERAL SERVICES GRANT
CLEVELAND CLINICAL FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195340174585501(C)(3)16999HOSPITALIST GRANT
Duke University Medical Center
2301 Erwin RoaddurhamNC27705562070036501(C)(3)11000preceptor fees: antithrombotic traineeship, oncology traineeship
EDWARD FOUNDATION
801 S WASHINGTONNAPERVILLEIL60540363723705501(C)(3)13480MEDICATION SAFETY GRANT
Henry Ford Hospital
2799 west grand blvddetroitMI48238381357020501(C)(3)10000award for excellence grant
THE JOHNS HOPKINS HOSPITAL
600 N WOLFE STREETBALTIMOREMD21287520591656501(C)(3)10000preceptor fees: ONCOLOGY TRAINEESHIP
KAISER PERMANENTE COLORADO
16601 E CENTRETECH PKWYAURORACO8001190458405916176520JUNIOR INVESTIGATOR GRANT
KALEIDA HEALTH
100 high StreetBuffaloNY14203161533232501(C)(3)50000award for excellence grant
MAYO CLINIC
200 First Street SWrochesterMN55905416011702501(C)(3)21500grants-emergency physician, pharmacy resident
MERITER HOSPITAL PHARMACY DEPARTMENT
202 s park streetmadisonWI53715390806367501(C)(3)8000preceptors fee: antithrombotic traineeship
Palo Alto Institute for Research & Education
431 Florence 200Palo AltoCA94301770207331501(C)(3)8250jr investigator grant
REGENTS OF UNIVERSITY OF CALIFORNIA
521 PARNASSUS AVENUESAN FRANCISCOCA941430622946036493501(C)(3)16396PRECEPTORS FEE: antithrombotic traineeship
rex healthcare institute
4420 Lake Boone TrailRaleighNC27607566052117501(C)(3)10000award for excellence grant
SAINT LUKE'S EPISCOPAL HOSPITAL
6720 BERTNERHOUSTONTX77030741161938501(C)(3)13080medication safety grant
UNIVERSITY OF CALIFORNIA SAN DIEGO MEDICAL CENTER
200 WEST ARBOR DRIVESAN DIEGOCA92103956006144501(C)(3)13480medication safety grant
UNIVERSITY OF IOWA
4 jessup halliowas cityIA52242426004813501(C)(3)13200medication safety team grant
UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER
1200 N Phillips AveOklahoma CityOK73104736017987501(C)(3)5000pharmacy resident grant
UNIVERSITY OF ROCHESTER MEDICAL CENTER
601 Elmwood AverochesterNY14642160743209501(C)(3)16500emergency physician grant
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
1515 holcombe blvdhoustonTX77030746000203501(C)(3)5000pharmacy resident grant
UNIVERSITY OF WASHINGTON MEDICAL CENTER
1959 NE Pacific streetseattleWA98101916001537501(C)(3)9000preceptor fees: antithrombotic and oncology traineeships
VA WESTERN NY HEALTHCARE SYSTEM
3495 Bailey AvebuffaloNY14215161447141501(C)(3)10000preceptor fees: antithrombotic traineeship
VIRGINIA COMMONWEALTH UNIVERSITY
PO BOX 980568RICHMONDVA2329805685460017581156533JUNIOR INVESTIGATOR GRANT
WISHARD MEMORIAL FOUNDATION INC
1001 WEST 10TH STREETiNDIANAPOLISIN462022879311132066501(C)(3)13198medication safety grant
FieldValueIRS element (for citing)
Total Nbr Of501 C3 And Govt Grants26TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations2TotalNbrOfOtherOrganizations

Form990 Schedule I Part III Form990ScheduleIPartIII (5 entries)

Type Of GrantTypeOfGrantNumber Of RecipientsNumberOfRecipientsAmount Of Cash GrantAmountOfCashGrant
leadership honoraria1025900
literature awards program917500
multisite special honoraria62314
student leadership awards2430000
oncology honoraria21000

Form990 Schedule I Part IV Form990ScheduleIPartIV

FieldValueIRS element (for citing)
IdentifierProcedure for Monitoring Grants in the U.S.:Identifier
Return ReferencePart I, Line 2:ReturnReference
ExplanationSchedule I, Part I, Line 2: THE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. ANY UNUSED GRANT FUNDS MUST BE RETURNED. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS.Explanation

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeXCompensationCommittee
Form990 Of Other OrganizationsXForm990OfOtherOrganizations
Written Employment ContractXWrittenEmploymentContract
Compensation SurveyXCompensationSurvey
Board Or Committee ApprovalXBoardOrCommitteeApproval
Severance Payment0SeverancePayment
Supplemental Nonqual Retire Plan0SupplementalNonqualRetirePlan
Equity Based Comp Arrangement0EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org0CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs0CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org0CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs0CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments0AnyNonFixedPayments
Initial Contract Exception0InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (3 entries)

Base Compensation Filing OrgBaseCompensationFilingOrgComp Based On Related OrgsCompBasedOnRelatedOrgsBonus Filing OrgBonusFilingOrgBonus Related OrgsBonusRelatedOrgsOther Compensation Filing OrgOtherCompensationFilingOrgOther Compensation Related OrgsOtherCompensationRelatedOrgsDeferred Comp Filing OrgDeferredCompFilingOrgDeferred Comp Related OrgsDeferredCompRelatedOrgsNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgNontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgsTotal Compensation Filing OrgTotalCompensationFilingOrgTotal Compensation Related OrgsTotalCompensationRelatedOrgsComp Report Prior990 Filing OrgCompReportPrior990FilingOrgComp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
HENRI R MANASSE JR PHD SCD
062249800021701060197021997072639300
STEPHEN J ALLEN MS FASHP
20723600010140024284095290251189000
RICHARD WALLING
1339290001707014825021330152594000

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (7 entries)

IdentifierIdentifierExplanationExplanation
Form 990, Part VI, Section A, line 2Business relationship - Michael S. Flagstead and Lynnae M. Mahaney.
Form 990, Part VI, Section A, line 7aTHREE MANDATORY MEMBERS OF THE FOUNDATIONS BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, EXECUTIVE VICE PRESIDENT, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND EXECUTIVE VICE PRESIDENT SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTHSYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD.
Form 990, Part VI, Section A, line 8bTHERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY.
Form 990, Part VI, Section B, line 11THE FORM 990 IS REVIEWED BY THE CHIEF OPERATIONS AND FINANCIAL OFFICERS AND BY THE BOARD (SERVING AS THE AUDIT COMMITTEE) BEFORE IT IS FILED. A COPY OF THE FORM 990 IS PROVIDED TO EACH MEMBER OF THE BOARD OF DIRECTORS.
Form 990, Part VI, Section B, line 12cANNUALLY AT THE MARCH MEETING
Form 990, Part VI, Section B, line 15aCEO, EXECUTIVE DIRECTOR OR TOP MANAGEMENT: A "CEO EVALUATION SUBCOMMITTEE" IS APPOINTED BY THE BOARD AND MEETS SEVERAL TIMES ON AN ANNUAL BASIS. THIS SUBCOMMITTEE IS RESPONSIBLE FOR EVAULATING CEO PERFORMANCE ANNUALLY AND NEGOTIATING A CONTRACT THAT CUSTOMARILY SPANS A 3-YEAR PERIOD. THE TREASURER CHAIRS THE SUBCOMMITTEE DURING THE CONTRACT RENEGOTIATION YEAR AND THE BOARD CHAIR LEADS THE SUBCOMMITTEE DURING NON-CONTRACT YEAR ANNUAL REVIEWS. ALL SUBCOMITTEE ACTIONS ARE REVIEWED BY THE FULL BOARD PRIOR TO TAKING ANY ACTIONS. ONE FULL YEAR PRIOR TO THE COMPLETION OF A CONTRACT CYCLE, THE SUBCOMMITTEE COORDINATES A 360-DEGREE PERFORMANCE REVIEW, SECURING INPUT FROM THE FOUNDATION AND ASHP STAFF, FOUNDATION VOLUNTEERS, AND REPRESENTATIVES FROM THE CORPORATE COMMUNITY WHO HAVE SPONSORED PROGRAMS FOR THE FOUNDATION. ADDITIONALLY, A CEO SELF-ASSESSMENT IS COMPLETED AND REVIEWED BY THE SUBCOMMITTEE. THE 360-DEGREE PERFORMANCE REVIEW AND SELF-ASSESSMENT IS CONSIDERED BY THE BOARD AND A DECISION IS MADE AS TO WHETHER THE BOARD DESIRES TO RENEGOTIATE A NEW CONTRACT WITH THE EXISTING CEO OR SEEK A REPLACEMENT. IF A REPLACEMENT IS DESIRED, THEN A SEARCH COMMITTEE IS APPOINTED. IF CONTRACT RENEGOTIATION WITH THE CURRENT CEO IS DESIRED, THE CEO EVALUATION COMMITTEE LEADS CONTRACT RENEGOTIATIONS UNDER THE LEADERSHIP OF THE TREASURER. A CONTRACT FOR THE BOARD'S CONSIDERATION IS ESTABLISHED IN WRITING WITH ALL PROVISIONS OUTLINED, INCLUDING COMPENSATION AND BENEFITS. TO DETERMINE PROPOSED COMPENSATION THE SUBCOMMITTEE REVIEWS 1) NATIONAL SURVEY DATA FOR CHIEF PHARMACY OFFICERS SINCE THIS IS A LIKELY AND COMPETITIVE CANDIDATE POOL FOR THE CEO POSITION, 2) THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVE (ASAE) COMPENSATION DATA FOR EXECUTIVES IS REVIEWED FOCUSING ON SIMILAR/COMPETITIVE HEALTHCARE ORGANIZATIONS IN THE MID-ATLANTIC REGION, AND 3) GUIDESTAR'S DATABASE IS REFERENCED TO IDENTIFY CEO COMPENSATION IN COMPETITIVE ORGANIZATION'S 990 FILINGS. ULTIMATELY, A NEW CONTRACT IS PRESENTED TO THE BOARD FOR APPROVAL THAT OUTLINES COMPENSATION AND PERFORMANCE EXPECTATIONS. IN NON-CONTRACT RENEWAL YEARS, THE SUBCOMMITTEE COMPLETES A DRAFT ANNUAL PERFORMANCE REVIEW FOR THE BOARDS CONSIDERATION PRIOR TO CONDUCTING THE ANNUAL PERFORMANCE REVIEW ALONG WITH A SET OF CEO PERFORMANCE OBJECTIVES FOR THE UPCOMING YEAR AND A CEO SELF-ASSESSMENT SUMMARY. IN ALL CASES CEO PERFORMANCE IS MEASURED AGAINST BOARD-APPROVED ANNUAL PERFORMANCE OBJECTIVES. OTHER OFFICERS OR KEY EMPLOYEES: THE CEO DETERMINES COMPENSATION FOR KEY EMPLOYEES RELYING HEAVILY UPON THE GUIDANCE OF THE HUMAN RESOURCES DEPARTMENT OF ASHP. ASAE SURVEY DATA IS REVIEWED WHEN COMPARABLE POSITIONS EXIST FOR THE KEY EMPLOYEE POSITION (E.G. DIRECTOR OF COMMUNICATIONS). THE HUMAN RESOURCES DEPARTMENT UTILIZES ADDITIONAL SALARY SURVEY DATABASES TO COMPARE SALARIES. FOR POSITIONS WHERE A PHARAMCIST IS A JOB REQUIREMENT, PHARMACIST POSITIONS IN HOSPITALS AND HEALTH-SYSTEMS THAT WOULD BE LIKELY CANDIDATE POOLS ARE QUERIED IN THE SALARY SURVEY DATABASES. ADDITIONALLY, THE HR DEPARTMENT CAN PROVIDE COMPARATIVE DATA FOR PHARMACIST POSITIONS AT ASHP.
Form 990, Part VI, Section C, line 19THE FOUNDATION'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST PER ITS ANNUAL REPORT. THE FOUNDATION ALSO MAKES ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE UPON REQUEST.

Schedule R IRS990ScheduleR

Form990 Schedule R Part II Form990ScheduleRPartII (2 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEINEINPrimary ActivitiesPrimaryActivitiesLegal Domicile StateLegalDomicileStateExempt Code SectionExemptCodeSectionDirect Controlling Entity NADirectControllingEntityNABusiness Name Line1DirectControllingEntityName/BusinessNameLine1
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP)
7272 WISCONSIN AVENUEBETHESDAMD20814520807628TO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSIONMD501(C)(6)N/A
7272 WISCONSIN BUILDING CORPORATION
7272 WISCONSIN AVENUEBETHESDAMD20814521760057TITLE HOLDING COMPANYMD501(C)(2)AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
FieldValueIRS element (for citing)
Receipt Of Int Ann Rents Royalties0ReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other Org1GiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other Org1GiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other Org0LoansOrGuaranteesFromOtherOrg
Sale Of Assets To Other Org0SaleOfAssetsToOtherOrg
Purchase Of Assets From Other Org0PurchaseOfAssetsFromOtherOrg
Exchange Of Assets0ExchangeOfAssets
Rental Of Facilities To Other Orgs0RentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other Orgs0RentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other Orgs0PerformOfServicesForOtherOrgs
Perform Of Services By Other Orgs0PerformOfServicesByOtherOrgs
Sharing Of Facilities1SharingOfFacilities
Sharing Of Paid Employees1SharingOfPaidEmployees
Reimbursement Paid To Other Org1ReimbursementPaidToOtherOrg
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrg
Other Transfer To Other Org0OtherTransferToOtherOrg
Other Transfer From Other Org1OtherTransferFromOtherOrg

Transactions Related Orgs Table TransactionsRelatedOrgsTable (6 entries)

Transaction TypeTransactionTypeAmount InvolvedAmountInvolved
aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
O1256531
aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
M672406
aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
R584125
aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
C321500
aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
N46421
aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
B26682

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.